PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 24, 2026The Lancet174 citations

Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial

View Full Paper
ZGZhen GeJKJing KanXGXiaofei Gao

Key Points

Key points are not available for this paper at this time.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ge et al. (2024) studied this question.

synapsesocial.com/papers/6a8c429f1cead5c89e872cdchttps://doi.org/10.1016/s0140-6736(24)00473-2
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes2007 · 6,713 citations
  2. 2Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS2020 · 182 citations